相关实验视频

Updated: Jun 16, 2025

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14⁺ Monocytes

Published on: April 11, 2025

斯宾林-1 抑制剂的免疫调节作用

Susanne Schiffmann^1,2, Marina Henke¹, Friedemann Weber³

¹Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, Germany.

Clinical and experimental immunology

|June 13, 2025

概括

斯宾林-1 抑制剂显示出抗癌潜力,但可能会抑制免疫系统. 这些药物抑制B细胞激活,可能增加感染风险,同时对巨细胞和T细胞产生轻微影响.

科学领域:

免疫学免疫学免疫学
癌症生物学癌症生物学
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.

背景情况:

斯宾林-1是一种新的表观遗传阅读器,也是潜在的癌症治疗点.
调节Spindlin-1对基因组标记的识别可能会影响免疫系统的抗癌能力.
了解Spindlin-1抑制剂对免疫细胞的影响对于治疗开发至关重要.

研究的目的:

研究斯宾林-1抑制对各种免疫细胞类型的影响.
为了区分斯宾林-1抑制剂A366和MS31的药物特异性和标特异性作用.
评估Spindlin-1向癌症治疗的潜在免疫调节后果.

主要方法:

对不同类型的免疫细胞进行了细胞毒性测试,以确定IC50值.
通过测量细胞因子和表面标记物表达,分析了巨细胞极化 (M1/M2).
在抑制剂治疗后评估了T细胞激活和B细胞增殖,分化和免疫球蛋白的产生.

主要成果:

斯宾林-1抑制剂A366和MS31在免疫细胞中表现出剂量依赖的细胞毒性,巨细胞比淋巴细胞更不敏感.
MS31诱导了M1到M2的巨细胞两极化,而这两种抑制剂都损害了M2两极化.
这两种抑制剂在低度下显著抑制了B细胞激活,增殖和免疫球蛋白的产生,而A366增加了B细胞代谢.

结论:

斯宾林-1抑制对巨细胞极化和T细胞激活的影响很小,但严重抑制了B细胞激活.
斯宾林-1 抑制剂可能具有双重作用:与抑制幽默性免疫反应一起具有抗癌作用.
针对Spindlin-1进行治疗可能会增加因体内免疫力受损而导致感染的易感性.

关键词:

A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A366 A367 A367 A368 A368 A368 A368 A368 A368 A368 A368 A368 A369 A310 A320 A320 A320 A320 A320 A320 A320 A320 A320 A320 A320 A320 A320 A320 美国MS3131 斯宾德林-1-1是什么意思细胞因子细胞因子能量代谢能量代谢免疫调节的免疫调节

更多相关视频

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Published on: February 28, 2025

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...